<--- Back to Details
First PageDocument Content
Technology / Pharmaceuticals policy / Medical technology / Food law / United States Public Health Service / Medical device / Federal Food /  Drug /  and Cosmetic Act / Regulatory requirement / In vitro diagnostics / Medicine / Food and Drug Administration / Health
Technology
Pharmaceuticals policy
Medical technology
Food law
United States Public Health Service
Medical device
Federal Food
Drug
and Cosmetic Act
Regulatory requirement
In vitro diagnostics
Medicine
Food and Drug Administration
Health

Microsoft Word - CDRH2011111 CompanionDx Final Guidance[removed]docx

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 159,23 KB

Share Document on Facebook

Similar Documents

The EU’s In Vitro Diagnostics (IVD) Regulation: a summary of the regulatory requirements for December 2017

DocID: 1v7Px - View Document

WELCOME ABOUT US • CE-MARKING • INTERNATIONAL REGISTRATION • QUALITY AND RISK MANAGEMENT • FULL SERVICE • EXPERTISE • CONTACT MEDICAL DEVICES & IN VITRO DIAGNOSTICS REGULATORY

DocID: 1sStC - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Medicine / Business / Health care / Abbott Laboratories / Lake Bluff /  Illinois / Medical tests / Alere / Point-of-care testing / In vitro / Blood type

2015 Business Review ABBOTT 2015 ANNUAL REPORT DIAGNOSTICS TIMELY INFORMATION

DocID: 1qQxr - View Document

Biological databases / Genomics / Biology / Bioinformatics / Molecular biology / Pharmacology / GeneTalk

Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics - Draft Guidance for Stakeholders and Food and Drug Administration Staff

DocID: 1pWKK - View Document